Pharmnovo Aktiebolag
Developing non-addictive delta opioid receptor agonists for neuropathic pain.
Översikt
- 1–4
- Anställda
- 10–20milj SEK
- Omsättning
- 2007
- Grundat
Nyckelbeslutsfattare
Karin Rosén
Member of the Board
Olof Breuer
MD, Clinical pharmacology lead
Johan Lund
Chairman and Member of the Board
Per von Mentzer
CEO
+3 fler kontakter i Funnelfeedr
Beskrivning
PharmNovo AB is a clinical-phase pharmaceutical company based in Lund, Sweden, focused on addressing the significant unmet medical need in chronic and neuropathic pain management. The company specializes in developing novel compounds based on selective delta opioid receptor agonists (DORAs). Their p...
Taggar
Nyckelord
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556739736801
Beslutsfattare
7 kontakter i FunnelfeedrKarin Rosén
Member of the Board
Olof Breuer
MD, Clinical pharmacology lead
Johan Lund
Chairman and Member of the Board
Per von Mentzer
CEO
Bengt von Mentzer
Founder
Petra Larson
Communications lead
Övriga kontakter
Johan Dighed
Chair of Disciplinary Committee
Liknande företag
20 liknande företag i Funnelfeedr
Synartro AB
1–4 anställdaDeveloping sustained local injection treatments for osteoarthritis pain relief.
Novo Nordisk Scandinavia AB
100–199 anställdaGlobal healthcare leader developing innovative medicines for serious diseases.
Novo Nordisk Farma Oy
Novo Nordisk Finland develops life-changing treatments for chronic diseases.
AcuCort AB
1–4 anställdaAcuCort develops and commercializes user-friendly, effective smart drugs.
VIFOR PHARMA NORDISKA AB
Global leader developing innovative therapies for iron deficiency and kidney disease.
Utforska mer
Frågor om Pharmnovo Aktiebolag
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo